Claves Fabien, Carras Sylvain, Burroni Barbara, Maitre Elsa, Boutonnat Jean, Troussard Xavier, Molina Lysiane
Hematology Department University Hospital of Grenoble Alpes Grenoble France.
Grenoble Alpes University Grenoble France.
EJHaem. 2024 Jan 9;5(1):242-246. doi: 10.1002/jha2.841. eCollection 2024 Feb.
Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder classically presenting with cytopenia and recurrent infections but atypical manifestations such as bone lesions, skin lesions and effusion have been described. We report here an unusual meningeal localization in a 33 years old man who presented with headache, hand paresthesia and visual symptoms. Brain magnetic resonance imaging revealed an occipital meningeal lesion. Diagnostic explorations led to the diagnosis of classical HCL with meningeal localization. After treatment by cladribine and rituximab the patient rapidly improved and is still in complete remission 12 months after end of treatment. The literature review identified 9 other cases of HCL with central nervous system localization (CNS) presenting with brain parenchyma and/or meninges localization. Four out of 9 patients presented with hyperleukocytosis. Most patients experienced good responses with various treatments. Cladribine alone or with rituximab led to complete responses similar to our patient. In our patient, molecular biology revealed KLF2 mutations, which implication in the atypical localization could be suspected but would need dedicated studies. In conclusion, CNS localizations of HCL are rare but can be observed and treatment with cladribine alone or with rituximab appears as an effective strategy.
毛细胞白血病(HCL)是一种罕见的淋巴增殖性疾病,典型表现为血细胞减少和反复感染,但也有诸如骨病变、皮肤病变和积液等非典型表现的报道。我们在此报告一例33岁男性患者的不寻常脑膜定位情况,该患者表现为头痛、手部感觉异常和视觉症状。脑部磁共振成像显示枕部脑膜病变。诊断性检查确诊为伴有脑膜定位的经典型HCL。经克拉屈滨和利妥昔单抗治疗后,患者迅速好转,治疗结束12个月后仍处于完全缓解状态。文献回顾发现另外9例中枢神经系统(CNS)定位的HCL病例,表现为脑实质和/或脑膜定位。9例患者中有4例出现白细胞增多。大多数患者经各种治疗后反应良好。单独使用克拉屈滨或联合利妥昔单抗治疗导致完全缓解,与我们的患者情况相似。在我们的患者中,分子生物学检测发现KLF2突变,其在非典型定位中的作用值得怀疑,但需要专门研究。总之,HCL的CNS定位罕见,但可以观察到,单独使用克拉屈滨或联合利妥昔单抗治疗似乎是一种有效的策略。